Teleflex Incorporated (NYSE:TFX) – Stock analysts at William Blair increased their FY2017 EPS estimates for Teleflex in a research report issued on Thursday. William Blair analyst B. Weinstein now anticipates that the medical technology company will post earnings of $8.26 per share for the year, up from their prior estimate of $8.12. William Blair also issued estimates for Teleflex’s FY2018 earnings at $9.55 EPS.
Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. During the same period in the prior year, the business posted $1.89 earnings per share. The company’s quarterly revenue was up 11.6% compared to the same quarter last year.
Shares of Teleflex (NYSE TFX) opened at 214.60 on Monday. Teleflex has a 12 month low of $136.53 and a 12 month high of $216.77. The stock has a market capitalization of $9.65 billion, a P/E ratio of 44.54 and a beta of 1.05. The firm’s 50-day moving average price is $207.61 and its 200-day moving average price is $195.00.
The company also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s payout ratio is presently 26.00%.
In other news, Director Stephen K. M.D. Klasko sold 5,200 shares of Teleflex stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $193.56, for a total transaction of $1,006,512.00. Following the sale, the director now owns 12,880 shares of the company’s stock, valued at approximately $2,493,052.80. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Stuart A. Randle sold 2,500 shares of Teleflex stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $205.67, for a total transaction of $514,175.00. Following the sale, the director now directly owns 7,532 shares in the company, valued at approximately $1,549,106.44. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,300 shares of company stock worth $1,643,975. Corporate insiders own 2.39% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the stock. Asset Planning Services Ltd. purchased a new stake in Teleflex during the first quarter valued at approximately $116,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Teleflex during the first quarter valued at approximately $155,000. OLD Mutual Customised Solutions Proprietary Ltd. raised its stake in Teleflex by 200.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock valued at $174,000 after buying an additional 600 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in Teleflex during the second quarter valued at approximately $200,000. Finally, Harvey Capital Management Inc. purchased a new stake in Teleflex during the second quarter valued at approximately $207,000. 93.02% of the stock is currently owned by hedge funds and other institutional investors.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
What are top analysts saying about Teleflex Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teleflex Incorporated and related companies.